Quantification of Parkinson's disease-related network expression with ECD SPECT

被引:59
作者
Eckert, Thomas
Van Laere, Koen
Tang, Chengke
Lewis, Daniel E.
Edwards, Christine
Santens, Patrick
Eidelberg, David
机构
[1] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Ctr Neurosci, Manhasset, NY 11030 USA
[2] Univ Magdeburg, Dept Neurol 2, D-39106 Magdeburg, Germany
[3] Katholieke Univ Leuven Hosp, Div Nucl Med, Louvain, Belgium
[4] Ghent Univ Hosp, Dept Neurol, B-9000 Ghent, Belgium
[5] N Shore Univ Hosp, Dept Neurol, New York, NY USA
[6] NYU, Sch Med, New York, NY USA
关键词
imaging; brain SPECT; perfusion; Parkinson's disease; multiple system atrophy;
D O I
10.1007/s00259-006-0261-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose Spatial covariance analysis has been used with FDG PET to identify a specific metabolic network associated with Parkinson's disease (PD). In the current study, we utilized a new, fully automated voxel-based method to quantify network expression in ECD SPECT images from patients with classical PD, patients with multiple system atrophy (MSA), and healthy control subjects. Methods We applied a previously validated voxel-based PD-related covariance pattern (PDRP) to quantify network expression in the ECD SPECT scans of 35 PD patients, 15 age- and disease severity-matched MSA patients, and 35 age-matched healthy control subjects. PDRP scores were compared across groups using analysis of variance. The sensitivity and specificity of the prospectively computed PDRP scores in the differential diagnosis of individual subjects were assessed by receiver operating characteristic (ROC) analysis. Results PDRP scores were significantly increased (p < 0.001) in the PD group relative to the MSA and control groups. ROC analysis indicated that the overall diagnostic accuracy of the PDRP measures was 0.91 (AUC). The optimal cutoff value was consistent with a sensitivity of 0.97 and a specificity of 0.80 and 0.71 for discriminating PD patients from MSA and normal controls, respectively. Conclusion Our findings suggest that fully automated voxel-based network assessment techniques can be used to quantify network expression in the ECD SPECT scans of parkinsonian patients.
引用
收藏
页码:496 / 501
页数:6
相关论文
共 36 条
[1]  
Alsop DC, 2000, ANN NEUROL, V47, P93, DOI 10.1002/1531-8249(200001)47:1<93::AID-ANA15>3.3.CO
[2]  
2-#
[3]   The metabolic pathology of dopa-responsive dystonia [J].
Asanuma, K ;
Ma, YL ;
Huang, CR ;
Carbon-Correll, M ;
Edwards, C ;
Raymond, D ;
Bressman, SB ;
Moeller, JR ;
Eidelberg, D .
ANNALS OF NEUROLOGY, 2005, 57 (04) :596-600
[4]   Network modulation in the treatment of Parkinson's disease [J].
Asanuma, Kotaro ;
Tang, Chengke ;
Ma, Yilong ;
Dhawan, Vijay ;
Mattis, Paul ;
Edwards, Christine ;
Kaplitt, Michael G. ;
Feigin, Andrew ;
Eidelberg, David .
BRAIN, 2006, 129 :2667-2678
[5]   FDG PET in the differential diagnosis of parkinsonian disorders [J].
Eckert, T ;
Barnes, A ;
Dhawan, V ;
Frucht, S ;
Gordon, MF ;
Feigin, AS ;
Eidelberg, D .
NEUROIMAGE, 2005, 26 (03) :912-921
[6]   The role of functional neuroimaging in the differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy [J].
Eckert, T ;
Eidelberg, D .
CLINICAL AUTONOMIC RESEARCH, 2004, 14 (02) :84-91
[7]   Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging [J].
Eckert, T ;
Sailer, M ;
Kaufmann, J ;
Schrader, C ;
Peschel, T ;
Bodammer, N ;
Heinze, HJ ;
Schoenfeld, MA .
NEUROIMAGE, 2004, 21 (01) :229-235
[8]   Neuroimaging and therapeutics in movement disorders [J].
Eckert T. ;
Eidelberg D. .
NeuroRX, 2005, 2 (2) :361-371
[9]   STRIATAL HYPOMETABOLISM DISTINGUISHES STRIATONIGRAL DEGENERATION FROM PARKINSONS-DISEASE [J].
EIDELBERG, D ;
TAKIKAWA, S ;
MOELLER, JR ;
DHAWAN, V ;
REDINGTON, K ;
CHALY, T ;
ROBESON, W ;
DAHL, JR ;
MARGOULEFF, D ;
FAZZINI, E ;
PRZEDBORSKI, S ;
FAHN, S .
ANNALS OF NEUROLOGY, 1993, 33 (05) :518-527
[10]   EARLY DIFFERENTIAL-DIAGNOSIS OF PARKINSONS-DISEASE WITH F-18 FLUORODEOXYGLUCOSE AND POSITRON EMISSION TOMOGRAPHY [J].
EIDELBERG, D ;
MOELLER, JR ;
ISHIKAWA, T ;
DHAWAN, V ;
SPETSIERIS, P ;
CHALY, T ;
BELAKHLEF, A ;
MANDEL, F ;
PRZEDBORSKI, S ;
FAHN, S .
NEUROLOGY, 1995, 45 (11) :1995-2004